Showing results (21-30 of 89) with videos related to

Sort By:
Pageof 9
European Journal of Clinical Pharmacology|February 7, 2023
Could the concomitant use of beta blockers with bevacizumab improve survival in metastatic colon cancer?Mehmet Zahid Kocak, Muhiddin Er, Muzaffer Ugrakli, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 12, 2021
Pazopanib-associated secondary adrenal insufficiency in a patient with malignant solitary fibrous tumorMuhammed Muhiddin Er, Murat Araz, Meryem Karabacak, et al.
Journal of Cancer Research and Therapeutics|July 20, 2023
Low-dose (7.5 mg/kg) bevacizumab may be a viable option in recurrent ovarian cancer: A retrospective studyAykut Demirkiran, Melek Karakurt Eryilmaz, Mustafa Karaagac, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 22, 2021
Pneumonitis associated with Trastuzumab emtansine in a patient with metastatic breast cancerMuzaffer Uğraklı, Murat Araz, Aykut Demirkıran, et al.
Journal of Gastrointestinal Cancer|June 21, 2019
The Prognostic Value of Serum Semaphorin3A and VEGF Levels in Patients with Metastatic Colorectal CancerTuba Karpuz, Murat Araz, Levent Korkmaz, et al.
Journal of Gastrointestinal Cancer|May 16, 2023
The Effect of RAS/BRAF Mutation Status on Prognosis and Relapse Pattern in Early Stage Colon CancersNazli Kunt, Murat Araz, Mahmut Selman Yildirim, et al.
Cancer Diagnosis & Prognosis|May 4, 2026
The Relationship Between Vascular Endothelial Growth Factor Expression in T Cell Subsets and Survival of Patients With Colorectal CancerMehmet Artaç, Ayça Ceylan, Oğuzhan Yildiz, et al.
Journal of Cancer Research and Therapeutics|June 14, 2023
Sunitinib-induced small bowel wall edema as a prognostic marker in metastatic renal cell carcinomaMustafa Korkmaz, Melek Karakurt Eryılmaz, Ülkü Kerimoğlu, et al.
Pageof 9